Tg Therapeutics (TGTX) Depreciation and Depletion (2011 - 2023)

Tg Therapeutics' Depreciation and Depletion history runs 13 years deep, the most recent figure standing at $73000.0 for Q3 2023.

• In Q3 2023, Depreciation and Depletion fell 3.95% year-over-year to $73000.0; the TTM figure through Sep 2023 stood at $246000.0 (down 20.65% YoY), while the FY2022 annual figure was $303000.0, up 7.45% from the prior year.
• Depreciation and Depletion was $73000.0 for Q3 2023 at Tg Therapeutics, up from $32000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $80000.0 in Q4 2021 to a low of $23000.0 in Q1 2019.
• Historically, Depreciation and Depletion has averaged $53473.7 across 5 years, with a median of $59000.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Depreciation and Depletion surged 97.06% in 2021, then sank 58.97% in 2023.
• A 5-year view of Depreciation and Depletion shows it stood at $28000.0 in 2019, then soared by 89.29% to $53000.0 in 2020, then jumped by 50.94% to $80000.0 in 2021, then fell by 8.75% to $73000.0 in 2022, then changed by 0.0% to $73000.0 in 2023.
• The last three Depreciation and Depletion figures came in at $73000.0 (Q3 2023), $32000.0 (Q2 2023), and $68000.0 (Q1 2023), per Business Quant data.